Thomas Schluep

7PUBLICATIONS
45CO-AUTHORS
Gene and molecular therapyMolecular targetsElemental semiconductorsPharmacogenomicsVirology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 08, 2025
Characterization of Hepatitis B Virus Transcripts in Chronically HBV-Infected Chimpanzees and Patients Treated with ARC-520 siRNA Demonstrates Transcriptional Silencing of cccDNA.

Christine I Wooddell, Dean Sanders, Zhao Xu

|Apr 23, 2024
A First-in-Human Phase 1 Study of a Tumor-Directed RNA-Interference Drug against HIF2α in Patients with Advanced Clear Cell Renal Cell Carcinoma.

James Brugarolas, Gregory Obara, Kathryn E Beckermann

|Oct 03, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and Humans.

Yuanqing Ma, Allison Joyce, Olivia Brandenburg

|Jun 24, 2022
Fazirsiran for Liver Disease Associated with Alpha1-Antitrypsin Deficiency.

Pavel Strnad, Mattias Mandorfer, Gourab Choudhury

|Jun 13, 2022
JNJ-73763989 pharmacokinetics and safety: Liver-targeted siRNAs against hepatitis B virus, in Japanese and non-Japanese healthy adults, and combined with JNJ-56136379 and a nucleos(t)ide analogue in patients with chronic hepatitis B.

Ed Gane, Man-Fung Yuen, Thomas N Kakuda

|Oct 27, 2019
RNA Interference Therapy With ARC-520 Results in Prolonged Hepatitis B Surface Antigen Response in Patients With Chronic Hepatitis B Infection.

Man-Fung Yuen, Ingolf Schiefke, Jung-Hwan Yoon

Pageof 2

Frequent Collaborators

3 joint publications

James Hamilton

2 joint publications

Christine I Wooddell

2 joint publications

James Brugarolas

2 joint publications

So Wong